Proteonomix, Inc.: Clinical Trials

2 trials sponsored by Proteonomix, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Completed 1

Follow Proteonomix, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Plerixafor for Stem Cell Mobilization in Normal Donors
Filgrastim, Plerixafor, Apheresis Procedure - Blood And Marrow Transplantation
Phase 2CompletedM.D. Anderson Cancer Center222013-10-012019-04-23
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Mobilization with G-CSF and Mozobil - End Stage Liver DIsease
Phase 1UnknownProteonomix, Inc.152012-10-012013-01-24

Conditions studied

End Stage Liver Disease (1)

Interventions

Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  plerixafor (2)  ·  Blood Component Removal (1)

Countries

United States (2)

Top investigators

Baburao Koneru, MD (1)  ·  Chitra M. Hosing, MD (1)